These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12720152)

  • 21. Preferential inhibition of T helper 1, but not T helper 2, cytokines in vitro by L-826,141 [4-[2-(3,4-Bisdifluromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]3-methylpyridine-1-oxide], a potent and selective phosphodiesterase 4 inhibitor.
    Claveau D; Chen SL; O'Keefe S; Zaller DM; Styhler A; Liu S; Huang Z; Nicholson DW; Mancini JA
    J Pharmacol Exp Ther; 2004 Aug; 310(2):752-60. PubMed ID: 15082748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [IMiDs in hematology].
    Wémeau M; Gauthier J; Leleu X; Yakoub-Agha I
    Bull Cancer; 2011 Aug; 98(8):879-87. PubMed ID: 21827980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of proteasome inhibition in Waldenström's macroglobulinemia.
    Roccaro AM; Sacco A; Leleu X; Azab AK; Azab F; Runnels J; Jia X; Ngo HT; Melhem M; Moreau AS; Ghobrial IM
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):94-6. PubMed ID: 19362985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalidomide analogs as emerging anti-cancer drugs.
    Dredge K; Dalgleish AG; Marriott JB
    Anticancer Drugs; 2003 Jun; 14(5):331-5. PubMed ID: 12782937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRIMA-1Met induces apoptosis in Waldenström's Macroglobulinemia cells independent of p53.
    Sobhani M; Abdi J; Manujendra SN; Chen C; Chang H
    Cancer Biol Ther; 2015; 16(5):799-806. PubMed ID: 25803193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of selective cytokine inhibitory drugs (CC-10004 and CC-1088) on VEGF and IL-6 expression and apoptosis in myeloma and endothelial cell co-cultures.
    Molostvov G; Morris A; Rose P; Basu S; Muller G
    Br J Haematol; 2004 Feb; 124(3):366-75. PubMed ID: 14717786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.
    Corral LG; Haslett PA; Muller GW; Chen R; Wong LM; Ocampo CJ; Patterson RT; Stirling DI; Kaplan G
    J Immunol; 1999 Jul; 163(1):380-6. PubMed ID: 10384139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current treatment options and investigational drugs for Waldenstrom's Macroglobulinemia.
    Gavriatopoulou M; Terpos E; Kastritis E; Dimopoulos MA
    Expert Opin Investig Drugs; 2017 Feb; 26(2):197-205. PubMed ID: 28043164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of p42/p44 MAPK, JNK, and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells.
    Lin FS; Lin CC; Chien CS; Luo SF; Yang CM
    J Cell Physiol; 2005 Feb; 202(2):464-73. PubMed ID: 15389584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JNK signaling involved in the effects of cyclic AMP on IL-1beta plus IFNgamma-induced inducible nitric oxide synthase expression in hepatocytes.
    Zhang B; Perpetua M; Fulmer M; Harbrecht BG
    Cell Signal; 2004 Jul; 16(7):837-46. PubMed ID: 15115662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
    Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
    J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
    Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
    J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo.
    Reddy N; Hernandez-Ilizaliturri FJ; Deeb G; Roth M; Vaughn M; Knight J; Wallace P; Czuczman MS
    Br J Haematol; 2008 Jan; 140(1):36-45. PubMed ID: 17995965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloidosis and Waldenström's macroglobulinemia.
    Gertz MA; Merlini G; Treon SP
    Hematology Am Soc Hematol Educ Program; 2004; ():257-82. PubMed ID: 15561687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
    Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
    Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiogenesis in Waldenstrom's macroglobulinemia.
    Rajkumar SV; Hayman S; Greipp PR
    Semin Oncol; 2003 Apr; 30(2):262-4. PubMed ID: 12720149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CC-1088 Celgene.
    Dredge K
    Curr Opin Investig Drugs; 2005 May; 6(5):513-7. PubMed ID: 15912966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.